SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

RAPT Therapeutics Q1 EPS $(0.560) Up From $(13.280) YoY

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.560) per share. This is a 95.78 percent increase over losses of $(13.280) per share from the same period last year.

Benzinga · 05/14/2020 12:05

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.560) per share. This is a 95.78 percent increase over losses of $(13.280) per share from the same period last year.